What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Pathology
His primary areas of study are Alzheimer's disease, Pittsburgh compound B, Pathology, Amyloid and Internal medicine.
His Alzheimer's disease research includes themes of Central nervous system disease, Posterior cingulate, Asymptomatic, Dementia and Precuneus.
His Pittsburgh compound B research integrates issues from Florbetaben, Positron emission tomography, Nuclear medicine, Magnetic resonance imaging and Cognitive disorder.
His Amyloid study combines topics from a wide range of disciplines, such as Genetically modified mouse, Imaging agent, In vivo and Biochemistry.
His studies in Internal medicine integrate themes in fields like Endocrinology, Neuroscience, Brain mapping and Oncology.
His research investigates the link between Alzheimer's disease biomarkers and topics such as White matter that cross with problems in Cortex.
His most cited work include:
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. (3385 citations)
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (1570 citations)
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. (1016 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Pathology, Amyloid, Internal medicine, Pittsburgh compound B and Positron emission tomography.
His biological study spans a wide range of topics, including Preclinical imaging and In vivo.
In general Amyloid study, his work on Cerebral amyloid angiopathy often relates to the realm of Congo red, thereby connecting several areas of interest.
Chester A. Mathis usually deals with Internal medicine and limits it to topics linked to Endocrinology and Serotonin and 5-HT receptor.
His Pittsburgh compound B research incorporates elements of Fluorodeoxyglucose, Down syndrome, Apolipoprotein E and Precuneus.
His Alzheimer's disease research is multidisciplinary, relying on both Central nervous system disease, Neuroscience, Degenerative disease, Dementia and Atrophy.
He most often published in these fields:
- Pathology (36.06%)
- Amyloid (27.88%)
- Internal medicine (26.60%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (26.60%)
- Pittsburgh compound B (24.30%)
- Endocrinology (17.14%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Pittsburgh compound B, Endocrinology, Amyloid and Down syndrome.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Hyperintensity.
The concepts of his Pittsburgh compound B study are interwoven with issues in Positron emission tomography and Precuneus.
His Endocrinology research is multidisciplinary, incorporating perspectives in Receptor, Antagonist and Psychosis.
His Amyloid research is multidisciplinary, incorporating elements of Biomedical engineering, Apolipoprotein E, Neuroscience and Cohort.
In general Pathology, his work in Senile plaques, Amyloidosis and Histology is often linked to Fluorescence microscope linking many areas of study.
Between 2016 and 2021, his most popular works were:
- Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies (114 citations)
- Multisite study of the relationships between antemortem [11C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology (49 citations)
- Small-molecule PET Tracers for Imaging Proteinopathies (41 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Disease
Chester A. Mathis focuses on Pittsburgh compound B, Internal medicine, Pathology, Alzheimer's disease and Dementia.
The subject of his Pittsburgh compound B research is within the realm of Amyloid.
His Internal medicine research incorporates themes from Major depressive disorder and Endocrinology.
The Pathology study combines topics in areas such as White matter, Entorhinal cortex and Basal ganglia.
His studies deal with areas such as Trail Making Test and Cognition, Neuroscience as well as Alzheimer's disease.
The various areas that Chester A. Mathis examines in his Dementia study include Biomarker, Gait, Preferred walking speed and Gerontology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
